Search Within

Hong-Fen Guo

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (29)
  2. Meeting Abstract (22)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (51)
  2. GSK Faculty (51)
  3. Neuroblastoma Service (51)
  4. Pediatrics, Department of (51)
  5. Sloan Kettering Institute Postdocs (51)
  6. Tow Center for Developmental Oncology (TCDO) (51)

More Groups

People
  1. Nai-Kong Cheung (51)
  2. Hong Xu (36)
  3. Steven Larson (27)
  4. Sarah Cheal (22)
  5. Darren Veach (19)
  6. Pat Zanzonico (16)

More People

Years
  1. 2024 (5)
  2. 2023 (5)
  3. 2022 (7)
  4. 2021 (9)
  5. 2020 (9)
  6. 2019 (1)

More Years

Publications
  1. Journal of Nuclear Medicine (15)
  2. Journal for ImmunoTherapy of Cancer (5)
  3. Cancer Research (4)
  4. Molecular Cancer Therapeutics (3)
  5. Nuclear Medicine and Biology (3)
  6. Blood (2)

More Publications

Publishers
  1. Society of Nuclear Medicine (15)
  2. American Association for Cancer Research (10)
  3. Biomed Central Ltd (6)
  4. American Society of Hematology (3)
  5. Elsevier Science Inc. (3)
  6. Ivyspring International Publisher (2)

More Publishers

Results (51)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A potent tetravalent T-cell-engaging bispecific antibody against CD33 in acute myeloid leukemia
    Journal Article

    Hoseini, S. S.; Guo, H.; Wu, Z.; Nakajima Hatano, M.; Cheung, N. K. V.
    Blood Advances (2018)

    Fulltext@MSK | Save
  • Curative multicycle radioimmunotherapy monitored by quantitative SPECT/CT-based theranostics, using bispecific antibody pretargeting strategy in colorectal cancer
    Journal Article

    Cheal, S. M.; Fung, E. K.; Patel, M.; Xu, H.; Guo, H. F.; Zanzonico, P. B.; Monette, S.; Wittrup, K. D.; Cheung, N. K. V.; Larson, S. M.
    Journal of Nuclear Medicine (2017)

    Fulltext@MSK | Save
  • Comparative efficacy and toxicity of (177)Lu- vs (90)Y-theranostic anti-HER2/anti-DOTA(metal) pretargeted radioimmunotherapy (anti-HER2 DOTA-PRIT) of HER2-expressing breast cancer xenografts with curative intent
    Meeting Abstract

    Cheal, S.; Fung, E.; Xu, H.; Guo, H. F.; Patel, M.; Bell, M.; Kalidindi, T.; Punzalan, B.; Zanzonico, P.; Wittrup, K.; more...
    Journal of Nuclear Medicine (2017)

    Fulltext@MSK | Save
  • Overcoming resistance to HER2-targeted therapy with a novel HER2/CD3 bispecific antibody
    Journal Article

    Lopez-Albaitero, A.; Xu, H.; Guo, H.; Wang, L.; Wu, Z.; Tran, H.; Chandarlapaty, S.; Scaltriti, M.; Janjigian, Y.; de Stanchina, E.; more...
    OncoImmunology (2017)

    Fulltext@MSK | Save
  • Antitumor efficacy of anti-GD2 IgG1 Is enhanced by Fc glyco-engineering
    Journal Article

    Xu, H.; Guo, H.; Cheung, I. Y.; Cheung, N. K. V.
    Cancer Immunology Research (2016)

    Fulltext@MSK | Save
  • Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity (86)Y- or (177)Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates
    Journal Article

    Cheal, S. M.; Xu, H.; Lee, S. G.; Guo, H. F.; Punzalan, B.; Chalasani, S.; Fung, E.; Jungbluth, A.; Zanzonico, P.; Carrasquillo, J.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2016)

    Fulltext@MSK | Save
  • Humanized affinity-matured monoclonal antibody 8H9 has potent antitumor activity and binds to FG loop of tumor antigen B7-H3
    Journal Article

    Ahmed, M.; Cheng, M.; Zhao, Q.; Goldgur, Y.; Cheal, S. M.; Guo, H. F. ; Larson, S. M.; Cheung, N. K. V.
    Journal of Biological Chemistry (2015)

    Fulltext@MSK | Save
  • Preclinical evaluation of multistep targeting of diasialoganglioside GD2 using an IgG-scFv bispecific antibody with high affinity for GD2 and DOTA metal complex
    Journal Article

    Cheal, S. M.; Xu, H.; Guo, H. F. ; Zanzonico, P. B.; Larson, S. M.; Cheung, N. K.
    Molecular Cancer Therapeutics (2014)

    Fulltext@MSK | Save
  • Imaging the norepinephrine transporter in neuroblastoma: A comparison of [18F]-MFBG and 123I-MIBG
    Journal Article

    Zhang, H.; Huang, R.; Cheung, N. K. V.; Guo, H.; Zanzonico, P. B.; Thaler, H. T.; Lewis, J. S.; Blasberg, R. G.
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: Potential implications for immune based therapy of human solid tumors
    Journal Article

    Xu, H.; Cheung, I. Y.; Guo, H. F. ; Cheung, N. K. V.
    Cancer Research (2009)

    Fulltext@MSK | Save